pCAD-POAF 3 Year Follow-up

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorChina National Center for Cardiovascular Diseases

About this trial

This study will include the subjects who enrolled in pCAD-POAF trial (NCT05009914) to observe clinical outcomes 3 years after surgery.

The primary outcome is the time to first occurrence of a composite of all-cause death, stroke, systemic embolism, myocardial infarction, unplanned cardiac rehospitalization, or post-discharge atrial fibrillation from randomization through 3 years after surgery.

The secondary outcomes are:the individual components of the primary composite outcome; unplanned all-cause rehospitalization; arrhythmias other than atrial fibrillation; premature atrial contraction and premature ventricular contraction burdens; heart rate variability parameters; quality-of-life scores; and other Holter-derived parameters.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

This study will include the subjects who enrolled in pCAD-POAF trial

Disqualifiers

This study will include the subjects who enrolled in pCAD-POAF trial

Trial population

The population enrolled previously in pCAD-POAF trial.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • no other intervention

    Other intervention

    This is a observational study.

Treatment groups

430 Participants
are divided into 2 treatment groups
Group A: Intervention group1 intervention
Group B: Control group1 intervention

Trial outcomes

Primary outcomes

1

A composite of all-cause death, stroke, systemic embolism, myocardial infarction, unplanned cardiac rehospitalization, or post-discharge atrial fibrillation.

The primary outcome was the time to first occurrence of a composite of all-cause death, stroke, systemic embolism, myocardial infarction, unplanned cardiac rehospitalization, or post-discharge atrial fibrillation from randomization through 3 years after surgery.

Time frame
3 year after the surgery

Secondary outcomes

1

the individual components of the primary composite outcome

the individual components of all-cause death, stroke, systemic embolism, myocardial infarction, unplanned cardiac rehospitalization, or post-discharge atrial fibrillation

Time frame
within 3 year after surgery
2

unplanned all-cause rehospitalization

unplanned all-cause rehospitalization

Time frame
within 3 year after surgery
3

premature atrial contraction and premature ventricular contraction burdens

premature atrial contraction and premature ventricular contraction burdens recorded by the 3-day continuous ECG monitoring

Time frame
3 year after surgery
4

Holter-derived parameter, mean heart rate

mean heart rate derived from the 3-day ECG monitoring

Time frame
3 year after the surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.